Researchers say that a generic version of a drug already on the market, which can suppress and prevent HIV, would still yield a 30% profit even if the current price were drastically reduced.

Read more:https://insightscare.com/new-hiv-drug-made-at-40-per-year-for-single-patient-can-suppress-and-prevent-hiv/

#BestOnlineHealthcar Magazine
#globalhealthcaremagazines
#besthealthcaremagazine
#HIVDrug

New HIV Drug made at $40 per year for Single patient Can Suppress and Prevent HIV

Researchers say that a generic version of a drug already on the market, which can suppress and prevent HIV, would still yield a 30% profit even if the current price were drastically reduced.

Insights Care
Double Duty: HIV Drug Maraviroc Takes On Dementia and Huntington’s Disease
Researchers at the University of Cambridge have found a way to enhance the brain’s self-cleaning process (autophagy) in mice with Huntington’s disease and dementia. They discovered that an existing HIV drug, maraviroc, can inhibit a switch (CCR5) that impairs autophagy, leading to a reduction in harmful protein build-up and potentially slowing down memory loss.
https://scitechdaily.com/double-duty-hiv-drug-maraviroc-takes-on-dementia-and-huntingtons-disease/ #HIVDrug #Maraviroc #Dementia #HuntingtonsDisease #autophagy #neurodegenerative
Double Duty: HIV Drug Maraviroc Takes On Dementia and Huntington’s Disease

HIV drug helps protect against build-up of dementia-related proteins in mouse brains. Cambridge scientists have shown how the brain’s ability to clear out toxic proteins is impaired in Huntington’s disease and other forms of dementia – and how, in a study in mice, a repurposed HIV drug was able t

SciTechDaily